HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plotz, F. B. Articles by Wildevuur, C. R. Search for Related Content PubMed PubMed Citation Articles by Plotz, F. B. Articles by Wildevuur, C. R.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 823-832, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Blood activation during neonatal extracorporeal life support

FB Plotz, W van Oeveren, RH Bartlett and CR Wildevuur
Department of Pediatrics, Neonatology, University Hospital, Groningen, The Netherlands.

Cardiopulmonary bypass for heart operations is associated with a whole body inflammatory reaction. The main factors involved in this reaction are the contact system and the complement system. The activation of the contact system is considered mainly responsible for impaired hemostasis because it affects platelet function. The activation of the complement system is considered the main cause for organ dysfunction, particularly of the lung, due to activation of leukocytes. This study in 10 neonates was undertaken to evaluate if there are effects of activation of the contact and the complement systems in neonatal extracorporeal life support comparable to those during cardiopulmonary bypass for cardiac operations. Two periods of blood activation during extracorporeal life support could be distinguished. The initial blood-material interaction at the onset of extracorporeal life support resulted in activation of both the contact and the complement systems. The contact activation was apparent by elevated factor XIIa-C1 esterase inhibitor complexes, decreased kallikrein inhibitory capacity, thrombin-antithrombin III formation, and moderate generation of fibrin(ogen) degradation products. The complement activation was characterized by elevated C3a, decreased leukocyte count, elastase release, and tumor necrosis factor- alpha production. This initial activation pattern subsided by 24 hours. A second activation period was observed 72 hours after the onset of extracorporeal life support, which was characterized only by increased clotting and fibrinolytic activity while no activation of the complement system was observed. We conclude that the initial activation pattern in extracorporeal life support is similar to that observed during cardiopulmonary bypass for cardiac operations. The contact activation that affects platelets might explain the continuous platelet consumption observed during extracorporeal life support. In this period, as in cardiopulmonary bypass, aprotinin given in the pump prime might be effective to prevent platelet consumption and impairment of hemostasis also in extracorporeal life support. The complement activation and leukocyte inflammatory reaction during the initial period are able to cause a capillary leak syndrome and might therefore explain the frequently observed temporary compromised lung function in extracorporeal life support. This reaction, as in cardiopulmonary bypass, might be reduced by the use of specific drugs or heparin coating also in extracorporeal life support. The cause of the second period of activation during extracorporeal life support requires further studies before adequate measures can be recommended.

This article has been cited by other articles:

				E. C. McGee Jr., P. M. McCarthy, and N. Moazami Temporary Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 507 - 534. [Full Text]

				E. Khoshbin, A. E. Dux, H. Killer, A. W Sosnowski, R. K Firmin, and G. J Peek A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators Perfusion, January 1, 2007; 22(1): 15 - 21. [Abstract] [PDF]

				S. F Marasco, A. Preovolos, K. Lim, and R. F Salamonsen Thoracotomy in adults while on ECMO is associated with uncontrollable bleeding Perfusion, January 1, 2007; 22(1): 23 - 26. [Abstract] [PDF]

				S Ichiba, H M Killer, R K Firmin, S Kotecha, A D Edwards, and D Field Pilot investigation of hypothermia in neonates receiving extracorporeal membrane oxygenation Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F128 - F133. [Abstract] [Full Text] [PDF]

				E. N. Morgan, T. H. Pohlman, C. Vocelka, A. Farr, G. Lindley, W. Chandler, J. M. Griscavage-Ennis, and E. D. Verrier Nuclear factor {kappa}B mediates a procoagulant response in monocytes during extracorporeal circulation J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 165 - 171. [Abstract] [Full Text] [PDF]

				N. Moazami and P. M. McCarthy Temporary Circulatory Support Card. Surg. Adult, January 1, 2003; 2(2003): 495 - 520. [Full Text]

				P. Tassani, H. Schad, C. Winkler, A. Bernhard, U. Ettner, S. L. Braun, G. P. Eising, E. Kochs, R. Lange, and J. A. Richter Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: Does it exist? J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 735 - 741. [Abstract] [Full Text]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				F. D. Pagani, K. D. Aaronson, F. Swaniker, and R. H. Bartlett The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device Ann. Thorac. Surg., March 1, 2001; 71 (2007): S77 - S81. [Abstract] [Full Text] [PDF]

				M. Nagashima, Y. Imai, K. Seo, M. Terada, M. Aoki, T. Shin'oka, and M. Koide Effect of hemofiltrated whole blood pump priming on hemodynamics and respiratory function after the arterial switch operation in neonates Ann. Thorac. Surg., December 1, 2000; 70(6): 1901 - 1906. [Abstract] [Full Text] [PDF]

				F. D. Pagani, K. D. Aaronson, D. B. Dyke, S. Wright, F. Swaniker, and R. H. Bartlett Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy Ann. Thorac. Surg., December 1, 2000; 70(6): 1977 - 1985. [Abstract] [Full Text] [PDF]

				A. K Biswas, L. Lewis, and J. F Sommerauer Aprotinin in the management of life-threatening bleeding during extracorporeal life support Perfusion, May 1, 2000; 15(3): 211 - 216. [Abstract] [PDF]

				A. H Stammers, E. D Rauch, L. D Willett, J. W Newberry, and K. F Duncan Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study Perfusion, March 1, 2000; 15(2): 161 - 168. [Abstract] [PDF]

				M. Struber, J. T. Cremer, B. Gohrbandt, C. Hagl, M. Jankowski, B. Volker, H. Ruckoldt, M. Martin, and A. Haverich Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1330 - 1335. [Abstract] [Full Text] [PDF]

				H. P Wendel, A. M Scheule, F. S Eckstein, and G. Ziemer Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces Perfusion, January 1, 1999; 14(1): 21 - 28. [Abstract] [PDF]

				K. Mellgren, G. Mellgren, S. Lundin, A. Wennmalm, and H. Wadenvik Effect of Nitric Oxide Gas on Platelets During Open Heart Operations Ann. Thorac. Surg., May 1, 1998; 65(5): 1335 - 1341. [Abstract] [Full Text] [PDF]

				F. Brus, W. van Oeveren, A. Okken, and S. B. Oetomo Number and Activation of Circulating Polymorphonuclear Leukocytes and Platelets Are Associated with Neonatal Respiratory Distress Syndrome Severity Pediatrics, May 1, 1997; 99(5): 672 - 680. [Abstract] [Full Text] [PDF]

				A. H Stammers, L. W Fristoe, K. Christensen, J. Deptula, R T. Sydzyik, D. Zavadil, and L. Willett Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case report Perfusion, March 1, 1997; 12(2): 143 - 149. [Abstract] [PDF]

				D. F Graves, J. M Chernin, M. Kurusz, and J. B Zwischenberger Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results Perfusion, November 1, 1996; 11(6): 461 - 466. [Abstract] [PDF]

				J. Petaja, K. Peltola, H. Sairanen, M. Leijala, R. Kekomaki, E. Vahtera, and M. A. Siimes FIBRINOLYSIS, ANTITHROMBIN III, AND PROTEIN C IN NEONATES DURING CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 665 - 671. [Abstract] [Full Text]

				K. Mellgren, M. Skogby, A. Jarnas, L. Friberg, H. Wadenvik, and G. Mellgren Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicone membrane and a hollow-fibre oxygenator Perfusion, September 1, 1996; 11(5): 383 - 388. [Abstract] [PDF]

				K. Mellgren, L. G. Friberg, G. Mellgren, T. Hedner, A. Wennmalm, and H. Wadenvik Nitric Oxide in the Oxygenator Sweep Gas Reduces Platelet Activation During Experimental Perfusion Ann. Thorac. Surg., April 1, 1996; 61(4): 1194 - 1198. [Abstract] [Full Text]

				J R. Upp Jr, P. E Bush, and J. B Zwischenberger Complications of neonatal extracorporeal membrane oxygenation Perfusion, July 1, 1994; 9(4): 241 - 256. [PDF]